home / stock / sppi / sppi news


SPPI News and Press, Spectrum Pharmaceuticals Inc. From 02/27/20

Stock Information

Company Name: Spectrum Pharmaceuticals Inc.
Stock Symbol: SPPI
Market: NASDAQ
Website: sppirx.com

Menu

SPPI SPPI Quote SPPI Short SPPI News SPPI Articles SPPI Message Board
Get SPPI Alerts

News, Short Squeeze, Breakout and More Instantly...

SPPI - Spectrum Pharmaceuticals, Inc.'s (SPPI) CEO Joseph Turgeon on Q4 2019 Results - Earnings Call Transcript

Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2019 Results Earnings Conference Call February 27, 2020, 04:30 PM ET Company Participants Shiv Kapoor - Vice President, Strategic Planning & Investor Relations Joseph Turgeon - Chief Executive Officer Kurt Gustafson - Chief Financial O...

SPPI - Spectrum Pharmaceuticals EPS misses by $0.08

Spectrum Pharmaceuticals (NASDAQ: SPPI ): Q4 Non-GAAP EPS of -$0.30 misses by $0.08 ; GAAP EPS of -$0.36 misses by $0.03 . Cash and cash equivalents of $64.42M Press Release More news on: Spectrum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,

SPPI - Spectrum Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Pipeline Update

BLA for ROLONTIS ® (eflapegrastim) accepted for FDA review - PDUFA date on October 24, 2020 Data from poziotinib Cohort 1 of ZENITH20 accepted for podium presentation on March 18 at 11 th Annual Congress on Pulmonary and Respiratory Medicine in Amsterdam Spectrum plans to...

SPPI - Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today it will host a conference call with management to discuss the fourth quarter and full year 2019 financial results, provide an update on the company's busine...

SPPI - Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum Oncology Day on February 13th

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage programs will be given at the Guggenheim Healthcare Talks Idea Forum Oncology Day ...

SPPI - Spectrum Pharmaceuticals: Stock Price Drop Vs Disappointing Clinical Data Provides Good Upside

On December 26 before market open, Spectrum Pharmaceuticals (NASDAQ: SPPI ) provided an update on its lead candidates poziotinib and ROLONTIS. The news was clearly not well-received, as the stock finished down 60% for the day. The reason the stock crashed is because the phase 2 ZENITH20 tr...

SPPI - Black Diamond Therapeutics Begins IPO Effort

Quick Take Black Diamond Therapeutics ( BDTX ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The company is developing a platform that identifies small molecule kinase inhibitors, which help to slow or stop cancer. BDTX is a ...

SPPI - Akorn And Conn: High Risk And High Reward

Every once in a while I like to check oversold stocks to find good stocks to buy. Since stocks generally move in cycles with a high peak and a low trough, an investor could just buy low and sell high. But some stocks stay oversold for long periods of time and may have a long term downward tren...

SPPI - RAD, FCEL among premarket gainers

Pintec Technology Holdings (NASDAQ: PT ) +97%  on agreement with China Unicom to expand handset financing. More news on: Pintec Technology Holdings Limited, FuelCell Energy, Inc., Flexion Therapeutics, Inc., Stocks on the move, Read more ...

SPPI - HEXO, SPPI, NLNK and ACST among midday movers

Gainers:  China Rapid Finance (NYSE: XRF ) +142% . More news on: China Rapid Finance Limited, Liquidia Technologies, Inc., NewLink Genetics Corporation, Stocks on the move, Read more ...

Previous 10 Next 10